Synlab begins bookbuilding for €1bn IPO

By Aidan Gregory
19 Apr 2021

Synlab, the German laboratory diagnostic services company, has set the terms for its €1bn plus IPO on the Frankfurt Stock Exchange.

In a regulatory filing, Synlab said that the initial price range for the flotation has been fixed at €18 to €23 a share, valuing the company at €4bn to €5bn.

The base deal consists of €400m of new shares issued by the company and between €495m to ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial